Researchers develop OLED-based optogenetic stimulators for neurosensory therapy
Researchers from the Fraunhofer IPMS, together with colleagues from the Max Planck Institute for Multidisciplinary Natural Sciences (MPI-NAT) are developing OLED-based optical stimulators for future cochlear implants.
The researchers explain that optogenetics is a method that uses light to control genetically modified cells in living tissues. By introducing light-sensitive proteins into cells, their activity can be precisely turned on and off with light pulses. This technique is commonly used in neuroscience to study the functions of nerve cells and to activate or inhibit specific neuronal populations.